Model
Edge
NRX Pharmaceuticals Inc.
0001864871
Filing type
4
Filing date
Nov 21, 2022
Updated
Nov 22, 2022 ยท 10:44 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership